BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1624250)

  • 1. Deoxyribonuclease activity in T and B lymphocytes of haemodialysed patients with uraemia.
    Adamiec R; Szewczyk Z; Szopa J
    Int Urol Nephrol; 1992; 24(1):95-101. PubMed ID: 1624250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is an increase of deoxyribonucleases activity in uraemic lymphocytes caused by their augmented synthesis in these cells?
    Adamiec R; Szewczyk Z; Szmidziński R; Szopa J
    Clin Chim Acta; 1993 Nov; 221(1-2):15-22. PubMed ID: 8149632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uraemic lymphocytes: analysis of their nuclease activity.
    Adamiec R; Szewczyk Z; Szmidziński R; Szopa J
    Int Urol Nephrol; 1993; 25(6):603-10. PubMed ID: 8175281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2.
    Fernández-Fresnedo G; Ramos MA; González-Pardo MC; de Francisco AL; López-Hoyos M; Arias M
    Nephrol Dial Transplant; 2000 Apr; 15(4):502-10. PubMed ID: 10727545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deoxyribonuclease activity in lymphocytes of patients with chronic renal failure treated conservatively.
    Adamiec R; Szewczyk Z; Prochera J; Szopa J
    Int Urol Nephrol; 1991; 23(4):371-82. PubMed ID: 1938234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in deoxyribonuclease activity in uraemic lymphocytes is caused by the cleavage of the largest polymerase I subunit.
    Adamiec R; Szewczyk Z; Sikorski AF; Szopa J
    Nephrol Dial Transplant; 1993; 8(4):319-24. PubMed ID: 8390006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of haemodialysis on immune response.
    Gombos EA; Jefferson DM; Bhat JG
    Proc Eur Dial Transplant Assoc; 1975; 11():367-73. PubMed ID: 1197260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of the activity of matrix DNA synthesis in the lymphocytes of patients after kidney transplantation and the role of the processes of degradation of DNA-dependent RNA polymerases in the overall cellular nucleolytic activity].
    Adamiec R; Szewczyk Z; Szopa J
    Pol Arch Med Wewn; 1991 Oct; 86(4):220-31. PubMed ID: 1813876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group I and group II phospholipases A2 in serum in uraemia.
    Peuravuori HJ; Funatomi H; Nevalainen TJ
    Eur J Clin Chem Clin Biochem; 1993 Aug; 31(8):491-4. PubMed ID: 8218580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum beta-endorphin in non-dialysed and haemodialysed patients with chronic renal failure.
    Trelewicz P; Grzeszczak W; Drabczyk R
    Int Urol Nephrol; 1994; 26(1):117-23. PubMed ID: 8026916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in various lymphocyte subpopulations in the peripheral blood of patients with chronic uremia during hemodialysis].
    Kroczak M
    Pol Arch Med Wewn; 1989 Jun; 81(6):336-42. PubMed ID: 2634251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum magnesium and nerve conduction velocity in uraemic patients on chronic haemodialysis.
    Cisari C; Gasco P; Calabrese G; Pratesi G; Gonella M
    Magnes Res; 1989 Dec; 2(4):267-9. PubMed ID: 2642071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma endothelin levels in patients with uraemia.
    Koyama H; Tabata T; Nishzawa Y; Inoue T; Morii H; Yamaji T
    Lancet; 1989 May; 1(8645):991-2. PubMed ID: 2565518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients.
    Vacher-Coponat H; Brunet C; Lyonnet L; Bonnet E; Loundou A; Sampol J; Moal V; Dussol B; Brunet P; Berland Y; Dignat-George F; Paul P
    Nephrol Dial Transplant; 2008 Apr; 23(4):1406-14. PubMed ID: 18029366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of insulin binding to erythrocyte insulin receptors in uraemia by haemodialysis.
    Milutinović S; Breyer D; Janković M; Stefović A; Molnar V; Mrzljak V; Rocić B
    Proc Eur Dial Transplant Assoc; 1983; 19():763-8. PubMed ID: 6348765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative effect of uraemia and cuprophane haemodialysis on natural killer cells.
    Cala S; Mazuran R; Kordić D
    Nephrol Dial Transplant; 1990; 5(6):437-40. PubMed ID: 2122320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-6-PD activity of the red cells in chronic renal failure.
    Mellissinos KG; Vlassopoulos KS; Drivas GJ; Tsoukandas AG
    Nephron; 1977; 18(3):156-61. PubMed ID: 870844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic QT interval analysis in uraemic patients receiving chronic haemodialysis.
    Genovesi S; Rivera R; Fabbrini P; Dossi C; Bonforte G; Mircoli L; Ferrari AU; Stella A; Stramba-Badiale M
    J Hypertens; 2003 Oct; 21(10):1921-6. PubMed ID: 14508199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleeding in renal failure: altered platelet function in chronic uraemia only partially corrected by haemodialysis.
    Remuzzi G; Livio M; Marchiaro G; Mecca G; de Gaetano G
    Nephron; 1978; 22(4-6):347-53. PubMed ID: 740096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The binding of 125I-fibrinogen to blood platelets in patients with chronic uraemia.
    Komarnicki M; Zozulińska M; Zawilska K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):638-41. PubMed ID: 2448203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.